Brief: Point72 Asset Management Reports 4.5% Passive Stake In Syndax Pharmaceuticals, As Of Oct 30 - SEC Filing
31/10/2023 20:36
Oct 31 (Reuters) - Syndax Pharmaceuticals Inc SNDX.O :
* POINT72 ASSET MANAGEMENT, L.P. REPORTS 4.5 PERCENT PASSIVE
STAKE
IN SYNDAX PHARMACEUTICALS, INC AS OF OCT 30 - SEC FILING
Further company coverage: SNDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syndax Pharmaceuticals
See all newsBrief: Syndax Announces Topline Results From Maxpire Phase 2 Trial Of Axatilimab In Idiopathic Pulmonary Fibrosis
Syndax says mid-stage trial of lung disease treatment fails main goal, ends development
Syndax Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Syndax Q2 revenue jumps 92% on Revuforj, Niktimvo demand
Brief: Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million